Journal of Experimental Medicine, Vol 183, 1185-1192, Copyright © 1996 by Rockefeller University Press

ARTICLES

A mutated beta-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes

PF Robbins, M El-Gamil, YF Li, Y Kawakami, D Loftus, E Appella and SA Rosenberg
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

A number of antigens recognized by tumor-reactive T cells have recently been identified. The antigens identified in mouse model systems appear, with one exception, to represent the products of mutated genes. In contrast, most of the antigens recognized by human tumor-reactive T cells reported to date appear to represent the products of non-mutated genes. Here we report the isolation of a cDNA clone encoding beta- catenin, which was shown to be recognized by the tumor-infiltrating lymphocyte (TIL) 1290, a HLA-A24 restricted melanoma-specific CTL line from patient 888. The cDNA clone, which was isolated from the autologous melanoma cDNA library, differed by a single base pair from the published beta-catenin sequence, resulting in a change from a serine to a phenylalanine residue at position 37. Normal tissues from this patient did not express the altered sequence, nor did 12 allogeneic melanomas, indicating that this represented a unique mutation in this patient's melanoma. A peptide corresponding to the sequence between amino acids 29 and 37 of the mutant gene product was identified as the T cell epitope recognized by TIL 1290. The observation that HLA-A24 binding peptides contain an aromatic or hydrophobic residue at position 9 suggested that the change at position 37 may have generated a peptide (SYLDSGIHF) which was capable of binding to HLA-A24, and a competitive binding assay confirmed this hypothesis. The beta-catenin protein has been shown previously to be involved in cell adhesion mediated through the cadherin family of cell surface adhesion molecules. The high frequency of mutations found in members of cellular adhesion complexes in a variety of cancers suggests that these molecules may play a role in development of the malignant phenotype.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

• Maccalli, C., Nonaka, D., Piris, A., Pende, D., Rivoltini, L., Castelli, C., Parmiani, G. (2007). NKG2D-Mediated Antitumor Activity by Tumor-Infiltrating Lymphocytes and Antigen-Specific T-Cell Clones Isolated from Melanoma Patients. Clin. Cancer Res. 13: 7459-7468 [Abstract] [Full Text]  
• Sabbatini, P., Odunsi, K. (2007). Immunologic Approaches to Ovarian Cancer Treatment. JCO 25: 2884-2893 [Abstract] [Full Text]  
• Fonsatti, E., Nicolay, H. J.M., Sigalotti, L., Calabro, L., Pezzani, L., Colizzi, F., Altomonte, M., Guidoboni, M., Marincola, F. M., Maio, M. (2007). Functional Up-regulation of Human Leukocyte Antigen Class I Antigens Expression by 5-aza-2'-deoxycytidine in Cutaneous Melanoma: Immunotherapeutic Implications. Clin. Cancer Res. 13: 3333-3338 [Abstract] [Full Text]  
• Parmiani, G., De Filippo, A., Novellino, L., Castelli, C. (2007). Unique Human Tumor Antigens: Immunobiology and Use in Clinical Trials. J. Immunol. 178: 1975-1979 [Abstract] [Full Text]  
• Sensi, M., Anichini, A. (2006). Unique Tumor Antigens: Evidence for Immune Control of Genome Integrity and Immunogenic Targets for T Cell-Mediated Patient-Specific Immunotherapy. Clin. Cancer Res. 12: 5023-5032 [Abstract] [Full Text]  
• Uemura, H., Fujimoto, K., Tanaka, M., Yoshikawa, M., Hirao, Y., Uejima, S., Yoshikawa, K., Itoh, K. (2006). A Phase I Trial of Vaccination of CA9-Derived Peptides for HLA-A24-Positive Patients with Cytokine-Refractory Metastatic Renal Cell Carcinoma.. Clin. Cancer Res. 12: 1768-1775 [Abstract] [Full Text]  
• Hodi, F. S. (2006). Well-Defined Melanoma Antigens as Progression Markers for Melanoma: Insights into Differential Expression and Host Response Based on Stage. Clin. Cancer Res. 12: 673-678 [Full Text]  
• Yoshiura, K., Nakaoka, T., Nishishita, T., Sato, K., Yamamoto, A., Shimada, S., Saida, T., Kawakami, Y., Takahashi, T. A., Fukuda, H., Imajoh-Ohmi, S., Oyaizu, N., Yamashita, N. (2005). Carbonic Anhydrase II Is a Tumor Vessel Endothelium-Associated Antigen Targeted by Dendritic Cell Therapy. Clin. Cancer Res. 11: 8201-8207 [Abstract] [Full Text]  
• Nagata, Y., Hanagiri, T., Takenoyama, M., Fukuyama, T., Mizukami, M., So, T., Ichiki, Y., Sugaya, M., Sugio, K., Yasumoto, K. (2005). Identification of the HLA-Cw*0702-Restricted Tumor-Associated Antigen Recognized by a CTL Clone from a Lung Cancer Patient. Clin. Cancer Res. 11: 5265-5272 [Abstract] [Full Text]  
• Yu, P., Lee, Y., Liu, W., Krausz, T., Chong, A., Schreiber, H., Fu, Y.-X. (2005). Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. JEM 201: 779-791 [Abstract] [Full Text]  
• Sensi, M., Nicolini, G., Zanon, M., Colombo, C., Molla, A., Bersani, I., Lupetti, R., Parmiani, G., Anichini, A. (2005). Immunogenicity without Immunoselection: A Mutant but Functional Antioxidant Enzyme Retained in a Human Metastatic Melanoma and Targeted by CD8+ T Cells with a Memory Phenotype. Cancer Res. 65: 632-640 [Abstract] [Full Text]  
• Ayyoub, M., Hesdorffer, C. S., Metthez, G., Stevanovic, S., Ritter, G., Chen, Y.-T., Old, L. J., Speiser, D., Cerottini, J.-C., Valmori, D. (2004). Identification of an SSX-2 Epitope Presented by Dendritic Cells to Circulating Autologous CD4+ T Cells. J. Immunol. 172: 7206-7211 [Abstract] [Full Text]  
• Huang, J., El-Gamil, M., Dudley, M. E., Li, Y. F., Rosenberg, S. A., Robbins, P. F. (2004). T Cells Associated with Tumor Regression Recognize Frameshifted Products of the CDKN2A Tumor Suppressor Gene Locus and a Mutated HLA Class I Gene Product. J. Immunol. 172: 6057-6064 [Abstract] [Full Text]  
• Madi, L., Bar-Yehuda, S., Barer, F., Ardon, E., Ochaion, A., Fishman, P. (2003). A3 Adenosine Receptor Activation in Melanoma Cells: ASSOCIATION BETWEEN RECEPTOR FATE AND TUMOR GROWTH INHIBITION. J. Biol. Chem. 278: 42121-42130 [Abstract] [Full Text]  
• Maccalli, C., Li, Y. F., El-Gamil, M., Rosenberg, S. A., Robbins, P. F. (2003). Identification of a Colorectal Tumor-Associated Antigen (COA-1) Recognized by CD4+ T Lymphocytes. Cancer Res. 63: 6735-6743 [Abstract] [Full Text]  
• Odunsi, K., Jungbluth, A. A., Stockert, E., Qian, F., Gnjatic, S., Tammela, J., Intengan, M., Beck, A., Keitz, B., Santiago, D., Williamson, B., Scanlan, M. J., Ritter, G., Chen, Y.-T., Driscoll, D., Sood, A., Lele, S., Old, L. J. (2003). NY-ESO-1 and LAGE-1 Cancer-Testis Antigens Are Potential Targets for Immunotherapy in Epithelial Ovarian Cancer. Cancer Res. 63: 6076-6083 [Abstract] [Full Text]  
• Novellino, L., Renkvist, N., Rini, F., Mazzocchi, A., Rivoltini, L., Greco, A., Deho, P., Squarcina, P., Robbins, P. F., Parmiani, G., Castelli, C. (2003). Identification of a Mutated Receptor-Like Protein Tyrosine Phosphatase {kappa} as a Novel, Class II HLA-Restricted Melanoma Antigen. J. Immunol. 170: 6363-6370 [Abstract] [Full Text]  
• Touloukian, C. E., Leitner, W. W., Schnur, R. E., Robbins, P. F., Li, Y., Southwood, S., Sette, A., Rosenberg, S. A., Restifo, N. P. (2003). Normal Tissue Depresses While Tumor Tissue Enhances Human T Cell Responses In Vivo to a Novel Self/Tumor Melanoma Antigen, OA1. J. Immunol. 170: 1579-1585 [Abstract] [Full Text]  
• Robbins, P. F., El-Gamil, M., Li, Y. F., Zeng, G., Dudley, M., Rosenberg, S. A. (2002). Multiple HLA Class II-Restricted Melanocyte Differentiation Antigens Are Recognized by Tumor-Infiltrating Lymphocytes from a Patient with Melanoma. J. Immunol. 169: 6036-6047 [Abstract] [Full Text]  
• Parmiani, G., Castelli, C., Dalerba, P., Mortarini, R., Rivoltini, L., Marincola, F. M., Anichini, A. (2002). Cancer Immunotherapy With Peptide-Based Vaccines: What Have We Achieved? Where Are We Going?. JNCI J Natl Cancer Inst 94: 805-818 [Abstract] [Full Text]  
• Wang, H. Y., Zhou, J., Zhu, K., Riker, A. I., Marincola, F. M., Wang, R.-F. (2002). Identification of a Mutated Fibronectin As a Tumor Antigen Recognized by CD4+T Cells: Its Role in Extracellular Matrix Formation and Tumor Metastasis. JEM 195: 1397-1406 [Abstract] [Full Text]  
• Tomkiel, J. E., Alansari, H., Tang, N., Virgin, J. B., Yang, X., VandeVord, P., Karvonen, R. L., Granda, J. L., Kraut, M. J., Ensley, J. F., Fernandez-Madrid, F. (2002). Autoimmunity to the Mr 32,000 Subunit of Replication Protein A in Breast Cancer. Clin. Cancer Res. 8: 752-758 [Abstract] [Full Text]  
• Khong, H. T., Rosenberg, S. A. (2002). Pre-Existing Immunity to Tyrosinase-Related Protein (TRP)-2, a New TRP-2 Isoform, and the NY-ESO-1 Melanoma Antigen in a Patient with a Dramatic Response to Immunotherapy. J. Immunol. 168: 951-956 [Abstract] [Full Text]  
• Kao, H., Marto, J. A., Hoffmann, T. K., Shabanowitz, J., Finkelstein, S. D., Whiteside, T. L., Hunt, D. F., Finn, O. J. (2001). Identification of Cyclin B1 as a Shared Human Epithelial Tumor-Associated Antigen Recognized by T Cells. JEM 194: 1313-1324 [Abstract] [Full Text]  
• Kiniwa, Y., Fujita, T., Akada, M., Ito, K., Shofuda, T., Suzuki, Y., Yamamoto, A., Saida, T., Kawakami, Y. (2001). Tumor Antigens Isolated from a Patient with Vitiligo and T-Cell-infiltrated Melanoma. Cancer Res. 61: 7900-7907 [Abstract] [Full Text]  
• Koesters, R., Hans, M. A., Benner, A., Prosst, R., Boehm, J., Gahlen, J., von Knebel Doeberitz, M. (2001). Predominant mutation of codon 41 of the {beta}-catenin proto-oncogene in rat colon tumors induced by 1,2-dimethylhydrazine using a complete carcinogenic protocol. Carcinogenesis 22: 1885-1890 [Abstract] [Full Text]  
• Satyamoorthy, K., Li, G., Vaidya, B., Patel, D., Herlyn, M. (2001). Insulin-like Growth Factor-1 Induces Survival and Growth of Biologically Early Melanoma Cells through Both the Mitogen-activated Protein Kinase and {beta}-Catenin Pathways. Cancer Res. 61: 7318-7324 [Abstract] [Full Text]  
• Beck-Engeser, G. B., Monach, P. A., Mumberg, D., Yang, F., Wanderling, S., Schreiber, K., Espinosa, R. III, Le Beau, M. M., Meredith, S. C., Schreiber, H. (2001). Point Mutation in Essential Genes with Loss or Mutation of the Second Allele: Relevance to the Retention of Tumor-Specific Antigens. JEM 194: 285-300 [Abstract] [Full Text]  
• Hanada, K.-i., Perry-Lalley, D. M., Ohnmacht, G. A., Bettinotti, M. P., Yang, J. C. (2001). Identification of Fibroblast Growth Factor-5 as an Overexpressed Antigen in Multiple Human Adenocarcinomas. Cancer Res. 61: 5511-5516 [Abstract] [Full Text]  
• Kurashige, T., Noguchi, Y., Saika, T., Ono, T., Nagata, Y., Jungbluth, A., Ritter, G., Chen, Y.-T., Stockert, E., Tsushima, T., Kumon, H., Old, L. J., Nakayama, E. (2001). NY-ESO-1 Expression and Immunogenicity Associated with Transitional Cell Carcinoma: Correlation with Tumor Grade. Cancer Res. 61: 4671-4674 [Abstract] [Full Text]  
• Echchakir, H., Mami-Chouaib, F., Vergnon, I., Baurain, J.-F., Karanikas, V., Chouaib, S., Coulie, P. G. (2001). A Point Mutation in the {{alpha}}-Actinin-4 Gene Generates an Antigenic Peptide Recognized by Autologous Cytolytic T Lymphocytes on a Human Lung Carcinoma. Cancer Res. 61: 4078-4083 [Abstract] [Full Text]  
• Zeng, G., Wang, X., Robbins, P. F., Rosenberg, S. A., Wang, R.-F. (2001). CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production. Proc. Natl. Acad. Sci. USA 10.1073/pnas.061507398v1 [Abstract] [Full Text]  
• Kawakami, Y., Wang, X., Shofuda, T., Sumimoto, H., Tupesis, J. P., Fitzgerald, E., Rosenberg, S. A. (2001). Isolation of a New Melanoma Antigen, MART-2, Containing a Mutated Epitope Recognized by Autologous Tumor-Infiltrating T Lymphocytes. J. Immunol. 166: 2871-2877 [Abstract] [Full Text]  
• Harada, M., Li, Y. F., El-Gamil, M., Rosenberg, S. A., Robbins, P. F. (2001). Use of an in Vitro Immunoselected Tumor Line to Identify Shared Melanoma Antigens Recognized by HLA-A*0201-restricted T Cells. Cancer Res. 61: 1089-1094 [Abstract] [Full Text]  
• Lo Muzio, L. (2001). A Possible Role for the Wnt~1 Pathway in Oral Carcinogenesis. CROBM 12: 152-165 [Abstract] [Full Text]  
• Qi, L., Rojas, J.-M., Ostrand-Rosenberg, S. (2000). Tumor Cells Present MHC Class II-Restricted Nuclear and Mitochondrial Antigens and Are the Predominant Antigen Presenting Cells In Vivo. J. Immunol. 165: 5451-5461 [Abstract] [Full Text]  
• Nishizaka, S., Gomi, S., Harada, K., Oizumi, K., Itoh, K., Shichijo, S. (2000). A New Tumor-Rejection Antigen Recognized by Cytotoxic T Lymphocytes Infiltrating into a Lung Adenocarcinoma. Cancer Res. 60: 4830-4837 [Abstract] [Full Text]  
• Poszepczynska, E., Bagot, M., Echchakir, H., Martinvalet, D., Ramez, M., Charue, D., Boumsell, L., Bensussan, A. (2000). Functional characterization of an IL-7-dependent CD4+CD8alpha alpha + Th3-type malignant cell line derived from a patient with a cutaneous T-cell lymphoma. Blood 96: 1056-1063 [Abstract] [Full Text]  
• Kawano, K., Gomi, S., Tanaka, K., Tsuda, N., Kamura, T., Itoh, K., Yamada, A. (2000). Identification of a New Endoplasmic Reticulum-resident Protein Recognized by HLA-A24-restricted Tumor-infiltrating Lymphocytes of Lung Cancer. Cancer Res. 60: 3550-3558 [Abstract] [Full Text]  
• Martelange, V., De Smet, C., De Plaen, E., Lurquin, C., Boon, T. (2000). Identification on a Human Sarcoma of Two New Genes with Tumor-specific Expression. Cancer Res. 60: 3848-3855 [Abstract] [Full Text]  
• Baurain, J.-F., Colau, D., van Baren, N., Landry, C., Martelange, V., Vikkula, M., Boon, T., Coulie, P. G. (2000). High Frequency of Autologous Anti-Melanoma CTL Directed Against an Antigen Generated by a Point Mutation in a New Helicase Gene. J. Immunol. 164: 6057-6066 [Abstract] [Full Text]  
• Jager, E., Nagata, Y., Gnjatic, S., Wada, H., Stockert, E., Karbach, J., Dunbar, P. R., Lee, S. Y., Jungbluth, A., Jager, D., Arand, M., Ritter, G., Cerundolo, V., Dupont, B., Chen, Y.-T., Old, L. J., Knuth, A. (2000). Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses. Proc. Natl. Acad. Sci. USA 97: 4760-4765 [Abstract] [Full Text]  
• Shih, I.-M., Yu, J., He, T.-C., Vogelstein, B., Kinzler, K. W. (2000). The {beta}-Catenin Binding Domain of Adenomatous Polyposis Coli Is Sufficient for Tumor Suppression. Cancer Res. 60: 1671-1676 [Abstract] [Full Text]  
• Nakao, M., Shichijo, S., Imaizumi, T., Inoue, Y., Matsunaga, K., Yamada, A., Kikuchi, M., Tsuda, N., Ohta, K., Takamori, S., Yamana, H., Fujita, H., Itoh, K. (2000). Identification of a Gene Coding for a New Squamous Cell Carcinoma Antigen Recognized by the CTL. J. Immunol. 164: 2565-2574 [Abstract] [Full Text]  
• Chiari, R., Foury, F., De Plaen, E., Baurain, J.-F., Thonnard, J., G. Coulie, P. (1999). Two Antigens Recognized by Autologous Cytolytic T Lymphocytes on a Melanoma Result from a Single Point Mutation in an Essential Housekeeping Gene. Cancer Res. 59: 5785-5792 [Abstract] [Full Text]  
• Gomi, S., Nakao, M., Niiya, F., Imamura, Y., Kawano, K., Nishizaka, S., Hayashi, A., Sobao, Y., Oizumi, K., Itoh, K. (1999). A Cyclophilin B Gene Encodes Antigenic Epitopes Recognized by HLA-A24-Restricted and Tumor-Specific CTLs. J. Immunol. 163: 4994-5004 [Abstract] [Full Text]  
• Wang, F., Bade, E., Kuniyoshi, C., Spears, L., Jeffery, G., Marty, V., Groshen, S., Weber, J. (1999). Phase I Trial of a MART-1 Peptide Vaccine with Incomplete Freund's Adjuvant for Resected High-Risk Melanoma. Clin. Cancer Res. 5: 2756-2765 [Abstract] [Full Text]  
• Koesters, R., Ridder, R., Kopp-Schneider, A., Betts, D., Adams, V., Niggli, F., Briner, J., Doeberitz, M. v. K. (1999). Mutational Activation of the {beta}-Catenin Proto-Oncogene Is a Common Event in the Development of Wilms' Tumors. Cancer Res. 59: 3880-3882 [Abstract] [Full Text]  
• Yang, D., Nakao, M., Shichijo, S., Sasatomi, T., Takasu, H., Matsumoto, H., Mori, K., Hayashi, A., Yamana, H., Shirouzu, K., Itoh, K. (1999). Identification of a Gene Coding for a Protein Possessing Shared Tumor Epitopes Capable of Inducing HLA-A24-restricted Cytotoxic T Lymphocytes inCancer Patients. Cancer Res. 59: 4056-4063 [Abstract] [Full Text]  
• Ronsin, C., Chung-Scott, V., Poullion, I., Aknouche, N., Gaudin, C., Triebel, F. (1999). A Non-AUG-Defined Alternative Open Reading Frame of the Intestinal Carboxyl Esterase mRNA Generates an Epitope Recognized by Renal Cell Carcinoma-Reactive Tumor-Infiltrating Lymphocytes In Situ. J. Immunol. 163: 483-490 [Abstract] [Full Text]  
• Tanzarella, S., Russo, V., Lionello, I., Dalerba, P., Rigatti, D., Bordignon, C., Traversari, C. (1999). Identification of a Promiscuous T-Cell Epitope Encoded by Multiple Members of the MAGE Family. Cancer Res. 59: 2668-2674 [Abstract] [Full Text]  
• Matsuo, M., Wada, H., Honda, S., Tawara, I., Uenaka, A., Kanematsu, T., Nakayama, E. (1999). Expression of Multiple Unique Rejection Antigens on Murine Leukemia BALB/c RL[IMAGE]1 and the Role of Dominant Akt Antigen for Tumor Escape. J. Immunol. 162: 6420-6425 [Abstract] [Full Text]  
• Wang, R., Wang, X., Atwood, A. C., Topalian, S. L., Rosenberg, S. A. (1999). Cloning Genes Encoding MHC Class II-Restricted Antigens: Mutated CDC27 as a Tumor Antigen. Science 284: 1351-1354 [Abstract] [Full Text]  
• Pardoll, D. M. (1999). Inducing autoimmune disease to treat cancer. Proc. Natl. Acad. Sci. USA 96: 5340-5342 [Full Text]  
• Maitre, N., Brown, J. M., Demcheva, M., Kelley, J. R., Lockett, M. A., Vournakis, J., Cole, D. J. (1999). Primary T-Cell and Activated Macrophage Response Associated with Tumor Protection Using Peptide/Poly-N-Acetyl Glucosamine Vaccination. Clin. Cancer Res. 5: 1173-1182 [Abstract] [Full Text]  
• Barth, A. I. M., Stewart, D. B., Nelson, W. J. (1999). T cell factor-activated transcription is not sufficient to induce anchorage-independent growth of epithelial cells expressing mutant beta -catenin. Proc. Natl. Acad. Sci. USA 96: 4947-4952 [Abstract] [Full Text]  
• Pötter, E., Bergwitz, C., Brabant, G. (1999). The Cadherin-Catenin System: Implications for Growth and Differentiation of Endocrine Tissues. Endocr. Rev. 20: 207-239 [Abstract] [Full Text]  
• Pieper, R., Christian, R. E., Gonzales, M. I., Nishimura, M. I., Gupta, G., Settlage, R. E., Shabanowitz, J., Rosenberg, S. A., Hunt, D. F., Topalian, S. L. (1999). Biochemical Identification of a Mutated Human Melanoma Antigen Recognized by CD4+ T Cells. JEM 189: 757-766 [Abstract] [Full Text]  
• Gaudin, C., Kremer, F., Angevin, E., Scott, V., Triebel, F. (1999). A hsp70-2 Mutation Recognized by CTL on a Human Renal Cell Carcinoma. J. Immunol. 162: 1730-1738 [Abstract] [Full Text]  
• Orsulic, S, Huber, O, Aberle, H, Arnold, S, Kemler, R (1999). E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation. J. Cell Sci. 112: 1237-1245 [Abstract]  
• Li, Y., Bharti, A., Chen, D., Gong, J., Kufe, D. (1998). Interaction of Glycogen Synthase Kinase 3beta with the DF3/MUC1 Carcinoma-Associated Antigen and beta -Catenin. Mol. Cell. Biol. 18: 7216-7224 [Abstract] [Full Text]  
• Wang, R.-F., Johnston, S. L., Zeng, G., Topalian, S. L., Schwartzentruber, D. J., Rosenberg, S. A. (1998). A Breast and Melanoma-Shared Tumor Antigen: T Cell Responses to Antigenic Peptides Translated from Different Open Reading Frames. J. Immunol. 161: 3596-3606 [Abstract] [Full Text]  
• Correale, P., Walmsley, K., Zaremba, S., Zhu, M., Schlom, J., Tsang, K. Y. (1998). Generation of Human Cytolytic T Lymphocyte Lines Directed Against Prostate-Specific Antigen (PSA) Employing a PSA Oligoepitope Peptide. J. Immunol. 161: 3186-3194 [Abstract] [Full Text]  
• Coste, A. d. L., Romagnolo, B., Billuart, P., Renard, C.-A., Buendia, M.-A., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A., Perret, C. (1998). Somatic mutations of the beta -catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA 95: 8847-8851 [Abstract] [Full Text]  
• Gueguen, M., Patard, J.-J., Gaugler, B., Brasseur, F., Renauld, J.-C., Van Cangh, P. J., Boon, T., Van den Eynde, B. J. (1998). An Antigen Recognized by Autologous CTLs on a Human Bladder Carcinoma. J. Immunol. 160: 6188-6194 [Abstract] [Full Text]  
• Bagot, M., Echchakir, H., Mami-Chouaib, F., Delfau-Larue, M.-H., Charue, D., Bernheim, A., Chouaib, S., Boumsell, L., Bensussan, A. (1998). Isolation of Tumor-Specific Cytotoxic CD4+ and CD4+CD8dim+ T-Cell Clones Infiltrating a Cutaneous T-Cell Lymphoma. Blood 91: 4331-4341 [Abstract] [Full Text]  
• Valmori, D., Fonteneau, J.-F., Lizana, C. M., Gervois, N., Lienard, D., Rimoldi, D., Jongeneel, V., Jotereau, F., Cerottini, J.-C., Romero, P. (1998). Enhanced Generation of Specific Tumor-Reactive CTL In Vitro by Selected Melan-A/MART-1 Immunodominant Peptide Analogues. J. Immunol. 160: 1750-1758 [Abstract] [Full Text]  
• Shichijo, S., Nakao, M., Imai, Y., Takasu, H., Kawamoto, M., Niiya, F., Yang, D., Toh, Y., Yamana, H., Itoh, K. (1998). A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes. JEM 187: 277-288 [Abstract] [Full Text]  
• Wang, R.-F., Johnston, S. L., Southwood, S., Sette, A., Rosenberg, S. A. (1998). Recognition of an Antigenic Peptide Derived from Tyrosinase-Related Protein-2 by CTL in the Context of HLA-A31 and -A33. J. Immunol. 160: 890-897 [Abstract] [Full Text]  
• Osanto, S. (1997). Vaccine Trials for the Clinician: Prospects for Tumor Antigens. The Oncologist 2: 284-299 [Abstract] [Full Text]  
• Mandruzzato, S., Brasseur, F., Andry, G., Boon, T., Bruggen, P. v. d. (1997). A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma. JEM 186: 785-793 [Abstract] [Full Text]  
• Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., Kinzler, K. W. (1997). Activation of beta -Catenin-Tcf Signaling in Colon Cancer by Mutations in beta -Catenin or APC. Science 275: 1787-1790 [Abstract] [Full Text]  
• Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., Polakis, P. (1997). Stabilization of beta -Catenin by Genetic Defects in Melanoma Cell Lines. Science 275: 1790-1792 [Abstract] [Full Text]  
• Dubey, P., Hendrickson, R. C., Meredith, S. C., Siegel, C. T., Shabanowitz, J., Skipper, J. C.A., Engelhard, V. H., Hunt, D. F., Schreiber, H. (1997). The Immunodominant Antigen of an Ultraviolet-induced Regressor Tumor Is Generated by a Somatic Point Mutation in the DEAD Box Helicase p68. JEM 185: 695-706 [Abstract] [Full Text]  
• Bloom, M. B., Perry-Lalley, D., Robbins, P. F., Li, Y., El-Gamil, M., Rosenberg, S. A., Yang, J. C. (1997). Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 Melanoma. JEM 185: 453-460 [Abstract] [Full Text]  
• Pai, L., Orsulic, S, Bejsovec, A, Peifer, M (1997). Negative regulation of Armadillo, a Wingless effector in Drosophila. Development 124: 2255-2266 [Abstract]  
• Naftzger, C., Takechi, Y., Kohda, H., Hara, I., Vijayasaradhi, S., Houghton, A. N. (1996). Immune response to a differentiation antigen induced by altered antigen: A study of tumor rejection and autoimmunity. Proc. Natl. Acad. Sci. USA 93: 14809-14814 [Abstract] [Full Text]  
• Wang, R.-F., Appella, E., Kawakami, Y., Kang, X., Rosenberg, S. A. (1996). Identification of TRP-2 as a Human Tumor Antigen Recognized by Cytotoxic T Lymphocytes. JEM 184: 2207-2216 [Abstract] [Full Text]  
• Zeng, G., Wang, X., Robbins, P. F., Rosenberg, S. A., Wang, R.-F. (2001). CD4+ T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: Association with NY-ESO-1 antibody production. Proc. Natl. Acad. Sci. USA 98: 3964-3969 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS